The antibody target used in this work is nucleolin, a protein present at the cell surface of highly proliferating cellular components of the tumor microenvironment34,35, that acts as a co-receptor in the binding and/or internalization of a range of molecules involved in angiogenesis and tumor growth36–38. This evidence concerns the gene NUCLEOLIN and neoplasm.